Genetic Factors of Predisposition and Clinical Characteristics of Rheumatoid Arthritis in Russian Patients
- PMID: 34070522
- PMCID: PMC8228085
- DOI: 10.3390/jpm11060469
Genetic Factors of Predisposition and Clinical Characteristics of Rheumatoid Arthritis in Russian Patients
Abstract
Rheumatoid arthritis (RA) is a multifactorial disease caused by a genetic predisposition and environmental factors. Predisposing alleles of various genes have a relatively small influence on the disease risk when they appear separately, but in combination, they predispose an individual to RA development. We genotyped 125 patients with RA including 60 SNPs and sequenced coding part of six genes by next-generation sequencing (NGS) technology on a target panel (IAD177464_185). According to our data, the alleles HLA-DRB1*04, HLA-DRB1*01, HLA-B*27, PTPN22 (rs2476601), TNF (rs1800629), TPMT (rs2842934), and IL4 (rs2243250), and genotypes HLA-DRB1*04:04, HLA-DRB1*01:16, PTPN22 (rs2476601), TPMT (rs2842934), were significantly associated with the RA development. Associations with clinical criteria (DAS28-CRP, HAQ-DI, and CDAI) and biochemical factors were investigated. We have shown that the PADI4 genotypes (rs11203367, rs2240340, rs11203366, and rs874881) are significantly associated with the baseline levels of DAS28-CRP, HAQ-DI, and CDAI; genotypes IL23R (rs7530511) and TNFRSF1A (rs748004, rs2228144) with the level of anti citrullinated peptide antibodies (ACPA); the genotypes DHODH (rs3213422) and MTHFR (rs180113) with the concentration of C-reactive protein (CRP); and the genotypes IL2RA (rs2104286), IRAK3 (rs11541076), and IL4R (rs1801275) with the level of rheumatoid factor (RF). Application of targeted NGS panel contributes to expanded genotyping to identify risk groups among the RA patients.
Keywords: NGS; genetic predisposition; genotyping; polymorphism; rheumatoid arthritis.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Genetic and Clinical Factors Associated with Olokizumab Treatment in Russian Patients with Rheumatoid Arthritis.J Pers Med. 2022 Apr 15;12(4):641. doi: 10.3390/jpm12040641. J Pers Med. 2022. PMID: 35455757 Free PMC article.
-
HLA-C alleles confer risk for anti-citrullinated peptide antibody-positive rheumatoid arthritis independent of HLA-DRB1 alleles.Rheumatology (Oxford). 2013 Nov;52(11):1973-82. doi: 10.1093/rheumatology/ket252. Epub 2013 Jul 30. Rheumatology (Oxford). 2013. PMID: 23901134
-
HLA-DRB1 Analysis Identified a Genetically Unique Subset within Rheumatoid Arthritis and Distinct Genetic Background of Rheumatoid Factor Levels from Anticyclic Citrullinated Peptide Antibodies.J Rheumatol. 2018 Apr;45(4):470-480. doi: 10.3899/jrheum.170363. Epub 2018 Feb 1. J Rheumatol. 2018. PMID: 29419463
-
[Is rheumatoid arthritis without anti-citrullinated peptide antibody a genetically distinct subset?].Nihon Rinsho Meneki Gakkai Kaishi. 2009 Dec;32(6):484-91. doi: 10.2177/jsci.32.484. Nihon Rinsho Meneki Gakkai Kaishi. 2009. PMID: 20046016 Review. Japanese.
-
Genetic implications in the pathogenesis of rheumatoid arthritis; an updated review.Gene. 2019 Jun 20;702:8-16. doi: 10.1016/j.gene.2019.03.033. Epub 2019 Mar 20. Gene. 2019. PMID: 30904715 Review.
Cited by
-
Deciphering autoimmune susceptibility: a meta-analysis of PTPN22 gene variants.Immunol Res. 2025 Mar 11;73(1):59. doi: 10.1007/s12026-025-09614-9. Immunol Res. 2025. PMID: 40067478 Review.
-
Genetic and Clinical Factors Associated with Olokizumab Treatment in Russian Patients with Rheumatoid Arthritis.J Pers Med. 2022 Apr 15;12(4):641. doi: 10.3390/jpm12040641. J Pers Med. 2022. PMID: 35455757 Free PMC article.
-
Personalized Medicine in Autoimmune Diseases.J Pers Med. 2021 Nov 11;11(11):1181. doi: 10.3390/jpm11111181. J Pers Med. 2021. PMID: 34834532 Free PMC article.
-
Genetic variant in SPAG16 is associated with the susceptibility of ACPA-positive rheumatoid arthritis possibly via regulation of MMP-3.J Orthop Surg Res. 2022 Nov 24;17(1):511. doi: 10.1186/s13018-022-03405-w. J Orthop Surg Res. 2022. PMID: 36434627 Free PMC article.
-
MTHFR c.665C>T and c.1298A>C Polymorphisms in Tailoring Personalized Anti-TNF-α Therapy for Rheumatoid Arthritis.Int J Mol Sci. 2023 Feb 18;24(4):4110. doi: 10.3390/ijms24044110. Int J Mol Sci. 2023. PMID: 36835522 Free PMC article.
References
-
- WHO [(accessed on 4 December 2012)]; Available online: http://www.who.int/chp/topics/rheumatic/en/
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous